lv
en
ru
lt
az
Investors
Corporate Governance
Financial Information
Financial News
Presentations
Documents
Information on Shares
Analysts
Shareholders’ Meetings
Investor contacts
Media
Latest News
Photo Library
Media Contacts
Careers
Personnel Policy
Vacancies
Application Form
Internship
Career Contacts
Contacts
Search
Home
Company
About Olainfarm
Business Strategy
Governance and Management
Structure
Supervisory Council
Board
Senior Executive Team
Olainfarm Worldwide
Responsibility
Licences and Certificates
Quality Policy
Environment Protection Policy
Participation in Projects
Ongoing projects
Completed projects
Awards
History
In memoriam
Products and Services
Products
Over the Counter (OTC)
Prescription Medicines
Food Supplements
APIs and Intermediates
APIs
Intermediates
Pharmacovigilance
For Patients and Other Stakeholders
For Physicians and Pharmacists
Services
QC/QA Services
Regulatory Services
APIs and Intermediates Development
Final Dosage Forms Development
Contract Manufacturing
Research and Development
R&D of APIs and Intermediates
R&D of Final Dosage Forms
Preclinical Trials
Clinical Trials
Cooperation
Shareholders
vil
Shareholders
07.27.2015
Investors
Corporate Governance
Structure
Supervisory Council
Board
Shareholders
Senior Executive Team
Financial Information
Financial News
Presentations
Documents
Information on Shares
Analysts
Shareholders’ Meetings
Investor Contacts
Search
Recent Posts
Olainfarm’s Sales in March Exceed 10 Million Euros. Three Months Consolidated Sales Results Show 13% Sales Increase
April 18, 2018
Recording of the Fourth Quarter 2017 Investor Conference Webinar
March 21, 2018
Sales of Olainfarm in February Increase by 33%
March 19, 2018
Olainfarm will hold Fourth Quarter 2017 Investor Conference Webinar
March 14, 2018
Statement by Irina Maligina, Guardian of Inheritance of Valerijs Maligins
March 7, 2018